Golfer’s elbow and when to see your doctor

Scottsdale, Arizona - The condition you’re describing sounds like golfer’s elbow. It’s a common injury typically associated with overuse, and isn’t limited to golfers. Self-care measures often are enough to take care of the problem. But, because you still have symptoms after icing it for several days, it would be a good idea to see your health care provider for an evaluation. He or she can then determine if you need additional treatment.

Savory Foods Recalls Pork Rinds

Washington, DC - Savory Foods, a Portsmouth, Ohio establishment, is recalling approximately 32,928 pounds of pork rind products due to misbranding and an undeclared allergen, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today. The product contains wheat, a known allergen which is not declared on the product label.

Younger heart attack survivors may face premature heart disease death

Dallas, Texas - For patients age 50 and younger, the risk of premature death after a heart attack has dropped significantly, but their risk is still almost twice as high when compared to the general population, largely due to heart disease and other smoking-related diseases, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

American Heart Association Urges Nation’s Pharmacies to Re-Think Selling Tobacco

Washington, DC - American Heart Association CEO Nancy Brown issued the following comments on new data from the Centers for Disease Control and Prevention published today in the American Journal of Preventive Medicine. The data came from Porter Novelli’s Summer Styles, a national survey that found 66 percent of adults 18 and over were strongly or somewhat in favor of banning the sale of all tobacco products in retail pharmacy stores:

FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling

Washington, DC - After an extensive review of the latest scientific evidence, the U.S. Food and Drug Administration announced that it is requiring class-wide changes to drug labeling, including patient information, to help inform health care providers and patients of the serious risks associated with the combined use of certain opioid medications and a class of central nervous system (CNS) depressant drugs called benzodiazepines.